Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

PURPOSE: We examined the safety and efficacy of the combination of S-1 and biweekly docetaxel in patients with previously treated advanced non-small-cell lung cancer (NSCLC). METHODS: Patients with previously treated advanced NSCLC were eligible if they had a performance status of 2 or less, were 80...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Oki, Yasunari, Hirose, Takashi, Yamaoka, Toshimitsu, Kusumoto, Sojiro, Shirai, Takao, Sugiyama, Tomohide, Okuda, Kentaro, Nakashima, Masanao, Murata, Yasunori, Ohmori, Tohru, Adachi, Mitsuru
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064900/
https://ncbi.nlm.nih.gov/pubmed/20556612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-010-1382-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados